Dinorah Hernández Melchor

Dinorah Hernández Melchor is a Doctoral Researcher at Max Planck Institute for Infection Biology, where Dinorah focuses on establishing CRISPR/Cas9 methodology for genetic modifications in stem cells. Prior to this, Dinorah worked as a Scientific Researcher at Ingenes, where Dinorah was involved in launching and managing the Regenerative Medicine project. With a background in Biotechnology, Dinorah has also held positions at Centro de Investigación y de Estudios Avanzados del IPN, Tecnologías DAAT, Beiersdorf, COBBYSA, and Lotto Bio Nano Laboratories, gaining experience in various research and development roles. Dinorah holds a PhD in Science, Technology, and Society, along with additional certifications in Business Management for Biotechnology-based Start-ups.